A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline

Details for Australian Patent Application No. 2004283805 (hide)

Owner Glaxo Group Limited

Inventors Gladwin, Asa Elisabeth

Agent Davies Collison Cave

Pub. Number AU-A-2004283805

PCT Pub. Number WO2005/040124

Priority 0322629.7 26.09.03 GB

Filing date 23 September 2004

Wipo publication date 6 May 2005

International Classifications

C07D 215/40 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/040124 Priority application(s): WO2005/040124

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283814-Tetrahydropyridine derivatives

2004283803-Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors